DK0578768T3 - Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len - Google Patents

Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len

Info

Publication number
DK0578768T3
DK0578768T3 DK92910661.5T DK92910661T DK0578768T3 DK 0578768 T3 DK0578768 T3 DK 0578768T3 DK 92910661 T DK92910661 T DK 92910661T DK 0578768 T3 DK0578768 T3 DK 0578768T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
upper gastrointestinal
deductible
treatment
gastrointestinal disorders
Prior art date
Application number
DK92910661.5T
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK0578768T3 publication Critical patent/DK0578768T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92910661.5T 1991-04-04 1992-03-13 Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len DK0578768T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04

Publications (1)

Publication Number Publication Date
DK0578768T3 true DK0578768T3 (da) 1996-02-05

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92910661.5T DK0578768T3 (da) 1991-04-04 1992-03-13 Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len

Country Status (16)

Country Link
EP (1) EP0578768B1 (da)
JP (1) JPH06506682A (da)
KR (1) KR100238565B1 (da)
AT (1) ATE128351T1 (da)
AU (1) AU665349B2 (da)
BR (1) BR9205827A (da)
CA (1) CA2106215C (da)
CZ (1) CZ282105B6 (da)
DE (1) DE69205158T2 (da)
DK (1) DK0578768T3 (da)
ES (1) ES2077417T3 (da)
GR (1) GR3017580T3 (da)
HU (1) HU213203B (da)
RU (1) RU2126249C1 (da)
SK (1) SK121293A3 (da)
WO (1) WO1992017164A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2146637C (en) * 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
FI955144L (fi) * 1993-04-30 1995-10-31 Procter & Gamble Päällystetyt farmaseuttiset koostumukset
EP0698393B1 (en) * 1993-05-19 2002-07-03 Hisamitsu Pharmaceutical Co., Inc. 3-l-MENTHOXY-PROPANE-1, 2-DIOL AS SOLUBILIZING AGENT AND EXTERNAL PREPARATION CONTAINING THE SAME
CA2169735A1 (en) * 1993-08-17 1995-02-23 Henry C. Caldwell Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
JPH09504293A (ja) * 1993-10-28 1997-04-28 ザ、プロクター、エンド、ギャンブル、カンパニー マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
BR9507199A (pt) * 1994-03-24 1997-09-09 Procter & Gamble Cellulose Formas de dose sólidas contendo bismuto
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CO4410201A1 (es) * 1994-07-20 1997-01-09 Colgate Palmolive Co Metodos y composiciones farmaceuticas para el tratamiento de transtornos gastricos
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US6627233B1 (en) 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
RU2192251C1 (ru) * 2001-05-25 2002-11-10 Дальневосточный государственный медицинский университет Способ снижения гликемии у больных сахарным диабетом ii типа с гастродуоденальными язвами
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
RU2257890C2 (ru) * 2003-10-06 2005-08-10 Марио Атилио Лос Способ получения устойчивых фармацевтических композиций в форме таблеток, содержащих омепразол, и фармацевтические композиции, полученные таким способом
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル

Also Published As

Publication number Publication date
CA2106215A1 (en) 1992-10-05
RU2126249C1 (ru) 1999-02-20
DE69205158D1 (de) 1995-11-02
CZ282105B6 (cs) 1997-05-14
HUT65881A (en) 1994-07-28
KR100238565B1 (ko) 2000-02-01
GR3017580T3 (en) 1995-12-31
CA2106215C (en) 1997-05-27
EP0578768A1 (en) 1994-01-19
AU665349B2 (en) 1996-01-04
DE69205158T2 (de) 1996-04-18
CZ226093A3 (en) 1994-04-13
JPH06506682A (ja) 1994-07-28
HU213203B (en) 1997-03-28
AU1761492A (en) 1992-11-02
HU9302970D0 (en) 1994-01-28
ATE128351T1 (de) 1995-10-15
ES2077417T3 (es) 1995-11-16
WO1992017164A1 (en) 1992-10-15
BR9205827A (pt) 1994-06-28
SK121293A3 (en) 1994-07-06
EP0578768B1 (en) 1995-09-27

Similar Documents

Publication Publication Date Title
DK0578768T3 (da) Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
DE60043318D1 (de) Synergistische kombination von pumafentrine und salmeterol
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
DE69617659D1 (de) Pharmazeutische zusammensetzungen, welche ausgewählte lanthankarbonathydrate enthalten
NO902280L (no) Ny poroes farmasoeytisk form og fremstilling derav.
DE60335639D1 (de) Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
DE69009684D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
NO923643L (no) Legemiddel for behandling av gastrointestinale forstyrrelser
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
KR910700059A (ko) 위장관의 장해 약제치료용 디메틸폴리실옥산사용
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
DK0519983T3 (da) Anvendelse af ketorolac til behandling af periodontal sygdom
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
ATE195868T1 (de) Pharmazeutische zusammensetzungen von gallium- komplexen von 3-hydroxy-4-pyronen
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
ATE195876T1 (de) Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren
Hawkey et al. Helicobacter pylori, NSAIDs, and peptic ulcers
NO982634D0 (no) Sammensetninger inneholdende vismut og ett eller flere antimikrobielle midler for forebygging og behandling av gastrointestinale forstyrrelser
SE9403861D0 (sv) Novel medicinal use
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa